BRIEF-AstraZeneca Naloxegol trial shows no imbalances in adverse effects

LONDON Tue Feb 26, 2013 2:13am EST

LONDON Feb 26 (Reuters) - AstraZeneca PLC : * Announces results from long-term safety trial of Naloxegol in patients with

opioid-induced constipation * The Naloxegol trial reported no imbalances in serious adverse events * Naloxegol commercialisation and launch in U.S. subject to

both FDA approval and DEA schedule determination

FILED UNDER:
A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article